ALiEM - Pharm Pearls

NOVEMBER 1, 2023

Clinical pharmacology, therapeutic use and potential of COMT inhibitors in Parkinson’s disease. 22 Aug 2018. Medicine (Baltimore) 1999;78(6):361-9. PMID 10575418 Kaakkola S. 2000 Jun;59(6):1233-50. PMID: 10882160 The meaning behind the color of urine. The Meaning Behind the Color of Urine – Urology Care Foundation.

Clinical Pharmacology 161

Clinical Pharmacology Dosage Compounding 161

PharmaShots

APRIL 6, 2023

A recent study published in the January 2023 issue of Clinical Pharmacology and Therapeutics described essential characteristics of a PD biomarker for biosimilar development.

Biosimilars 53

Biosimilars Clinical Pharmacology 53

RX Note

JANUARY 21, 2023

Regardless, this post is solely created as a collection of recommended reference.

Compounding 40

Compounding Community Pharmacies Clinical Pharmacology Dosage 40

Big Molecule Watch

SEPTEMBER 25, 2023

Last week, FDA released a draft guidance, “ Labeling for Biosimilar and Interchangeable Biosimilar Products ” (“2023 Draft Guidance”) that—when finalized—will revise and replace its July 2018 final guidance, “ Labeling for Biosimilar Products.”

Labelling 62

Labelling Biosimilars Adverse Reactions Dosage 62

The Thyroid Pharmacist

DECEMBER 28, 2022

Interestingly, Dr. Robert Krysiak and colleagues from the Department of Internal Medicine and Clinical Pharmacology at the Medical University of Silesia in Katowice, Poland, published an article about the benefits of the gluten-free diet in Hashimoto’s in 2019. Accessed February 25, 2018. link] Updated March 7, 2018.

Immunity 110

Immunity Immunization Doctor of Pharmacy Clinical Pharmacology 110

PharmaShots

MARCH 9, 2023

and medical doctor in clinical pharmacology Other Affiliations: She is a member of the Board of Directors of L’Oréal S.A Award & Nominations: Fiona has been awarded with the Prize for Women in Pharmacology from Astra Zeneca issued by the British Pharmacological Society in December 2018.

Clinical Pharmacology 40

Clinical Pharmacology Immunity Immunization Pharmaceutical Companies 40

Eye on FDA

AUGUST 4, 2021

At the same time, looking to 2018 when there were 29 meetings to consider new drugs, the number appears to be falling each year, with only 6 that occurred during the first half of 2021. Fewer meetings – more approvals. The most active of these committees with vacancies this year has been the Oncologic Drugs Advisory Committee.

Clinical Pharmacology 122

Clinical Pharmacology Compounding Vaccines 122